A detailed history of Act Two Investors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Act Two Investors LLC holds 3,176 shares of JNJ stock, worth $497,774. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,176
Previous 3,506 9.41%
Holding current value
$497,774
Previous $554,000 16.25%
% of portfolio
0.09%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $47,645 - $52,067
-330 Reduced 9.41%
3,176 $464,000
Q1 2024

May 09, 2024

SELL
$155.22 - $162.74 $1.29 Million - $1.35 Million
-8,284 Reduced 70.26%
3,506 $554,000
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $1.72 Million - $1.87 Million
11,790 New
11,790 $1.85 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $5.62 Million - $6.05 Million
36,413 Added 60.1%
97,001 $16.1 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $9.15 Million - $10.9 Million
60,588 New
60,588 $9.39 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $2.02 Million - $2.24 Million
-12,973 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $1.18 Million - $1.31 Million
-7,315 Reduced 36.06%
12,973 $2.1 Million
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $192,173 - $206,139
-1,205 Reduced 5.61%
20,288 $3.34 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $23,572 - $26,253
154 Added 0.72%
21,493 $3.53 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $361,833 - $415,325
2,639 Added 14.11%
21,339 $3.36 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $55,207 - $63,408
-433 Reduced 2.26%
18,700 $2.73 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $54,969 - $61,546
433 Added 2.32%
19,133 $2.48 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $2.3 Million - $2.76 Million
18,700 New
18,700 $2.41 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Act Two Investors LLC Portfolio

Follow Act Two Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Two Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Two Investors LLC with notifications on news.